All Comments by Jochen Herms
Go to another page:
- 1
- 2
- First Evidence for Transmitted Alzheimer’s Disease?
- Fresh Brain Every Friday: Biopsies Transform Alzheimer's Science
- Sylvain Lesné, Who Found Aβ*56, Accused of Image Manipulation
- Mild COVID Infection Can Shrink Brain, Speed Cognitive Decline
- Single Synapse Mass Spec Snags CD47 as Alzheimer’s Resilience Factor
- Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat.
- Peering Inside Stubby and Mushroom Dendritic Spines
- BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
- Picking Through the Rubble, Field Tries to Salvage BACE Inhibitors
- Biogen/Eisai Halt Phase 3 Aducanumab Trials
- Scratch Lanabecestat: This BACE Inhibitor Doesn’t Work in Symptomatic AD, Either
- Merck Axes Verubecestat for Prodromal AD, Researchers Say ‘Go Earlier’
- Chimeric AD Model Shows Human Neurons Are Uniquely Vulnerable to Aβ
- Ocular indicators of Alzheimer's: exploring disease in the retina.
- Merck Pulls Plug on Phase 2/3 BACE Inhibitor Trial